Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-06-25

Clinical Trial Update: Use of Varenicline for 4-weeks Prior to Quitting [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated starting varenicline four weeks before quitting smoking, with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Varenicline (varenicline)

Snippet

Sponsor: Queen Mary University of London | Conditions: Tobacco Dependence, Smoking Cessation | Phase 3 | Status: COMPLETED | Results posted: 2012-06-25